1-3 of 3
Jerry Radich, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prognostic Methylation Markers for Survival in Cytogenetically Normal AML Patients Treated on SWOG Trials

Xiaoyu Qu, PhD, Megan Othus, PhD, Jerry Davison, PhD, Liying Yan, Elihu H. Estey, MD, Jerry Radich, MD, Harry P Erba, MD PhD, Frederick R. Appelbaum, MD, Min Fang, MD PhD
Journal: Blood
Blood (2015) 126 (23): 688.
https://doi.org/10.1182/blood.V126.23.688.688
Published: 2015
Journal Articles

Continuing Reduction in Level of Residual Disease after 4 Years in Patients with CML in Chronic Phase Responding to First-Line Imatinib (IM) in the IRIS Study.

John M. Goldman, MD, Timothy Hughes, MD, Jerry Radich, MD, Susan Branford, PhD, Andreas Hochhaus, MD, Charlene So, PharmD, Insa Gathmann, MS, Elisabeth Wehrle, Jaspal Kaeda, PhD
Journal: Blood
Blood (2005) 106 (11): 163.
https://doi.org/10.1182/blood.V106.11.163.163
Published: 2005
Journal Articles

Nonmyeloablative Conditioning and Hematopoietic Cell Transplantation (HCT) from HLA-Matched Related or Unrelated Donors for Chemotherapy-Refractory Chronic Lymphocytic Leukemia (CLL).

Mohamed Sorror, MD, MSc, Michael Maris, MD, Barry Storer, PhD, Brenda Sandmaier, MD, Monic Stuart, MD, Ute Hegenbart, MD, Edward Agura, MD, Thomas Chauncey, MD, Jose Leis, MD, PhD, Michael Pulsipher, MD, Peter McSweeney, MD, Jerry Radich, MD, James Wade, MD, Benedetto Bruno, MD, Amelia Langston, MD, Dietger Niederwieser, MD, Karl Blume, MD, Rainer Storb, MD, David Maloney, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 2323.
https://doi.org/10.1182/blood.V104.11.2323.2323
Published: 2004